CLINICAL_TRIALS
trial_result
· 2021-01-28
Clinical Trial Update: Immunogenicity and Safety of a Purified Vero Rabies Vaccine [Phase 2]
Summary
Phase 2 trial update on immunogenicity and safety of a purified Vero Rabies vaccine.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Rabies Virus | Phase 2 | Status: COMPLETED | Results posted: 2021-01-28